Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Belgian national telecoms provider joins COCIR

This article was originally published in Clinica

Executive Summary

Belgacom, the Belgium national telecoms provider, has joined the European radiological, electromedical and healthcare IT industry association COCIR. Christian Dezangré, Business Innovation Manager Health at Belgacom said: “The communications industry is at a critical point in its evolution. The health sector is seen as one of the key domains where the use of Belgacom’s ICT assets is allowing the development of innovative business values for users. Belgacom is actively supporting the Belgian stakeholders in their move to eHealth solutions.”

You may also be interested in...



Belgium Bans COVID-19 Antibody Self-Tests But UK Goes Ahead

While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers the tests not sufficiently accurate to be used in the pandemic.

Latest UK COVID-19 Specification: For Rapidly Manufactured CPAP Systems

Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.

Did The UK Government Really Spurn EU Ventilator Procurement Support?

The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.

Topics

UsernamePublicRestriction

Register

MT095045

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel